SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000122
Filing Date
2018-11-14
Accepted
2018-11-14 16:17:57
Documents
6
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-form8xk3qearningsrele.htm 8-K 28839
2 EXHIBIT 99.1 sesnq32018pressreleasefi.htm EX-99.1 14929
3 sesnq32018pressreleasefi001.jpg GRAPHIC 211254
4 sesnq32018pressreleasefi002.jpg GRAPHIC 265408
5 sesnq32018pressreleasefi003.jpg GRAPHIC 93004
6 sesnq32018pressreleasefi004.jpg GRAPHIC 106100
  Complete submission text file 0001485003-18-000122.txt   976267
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 181184042
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1